
Clinical Trials
Welcome to Clear Choice Dermatology’s Research Center.
Dermatology research close to home
A Clinical Research Facility in Warrenton, Oregon
Prioritizing patient care through quality clinical research trials is a top concern. Established alongside our dermatology clinic by Dr. Collin Blattner, Clear Choice Dermatology's research center is a privately-owned and operated research site that specializes in dermatology Phase I-IV clinical trials. As one of the Pacific Northwest's leading dermatology sites, Clear Choice Dermatology's research center aims to provide high-quality, verifiable data to our sponsors by consistently meeting or exceeding our recruitment goals.
Thank you for considering Clear Choice Dermatology's Research Center!

Our Amenities Include:
- Ambient and refrigerated centrifuges.
- -80° Celsius freezer.
- Secured and access-controlled study drug and materials storage.
- A fully equipped, research-exclusive patient room.
- Emergency medications, AED, and oxygen.
- A private monitoring space with access to internet, copier, and shipping supplies.
- Daily shipment and courier service.
- Research specimen processing laboratory.
- Annually calibrated site equipment, including (but not limited to): EKG machine, Healthscape Monitor for electronic vital signs, Health-O-Meter precision scale with height and BMI calculator, autoclave, hyfrecators, incubator, microscopes, and continuous 24/7 cloud-based temperature monitoring devices (for ambient, refrigerated, and frozen temperatures) with remote alarming.
Site:
- Nationally recognized, board-certified acting primary investigator.
- Board-certified dermatologist as acting sub-investigator.
- Fast regulatory and budget contract turnaround (average timeline of two weeks).
- Established SOPs with documented site-wide training.
- CLIA certification.
- Onsite drug destruction capability
- Access to 911 emergency response; site is conveniently located less than 7 miles from the nearest hospital.
- Central IRB utilization.
- Onsite and remote monitoring visit accommodation.
Staff:
- Experienced investigators and clinical research staff.
- Vast knowledge and experience with eDiaries, ePros, IWRS, EDCs, and other protocol-specific activities.
- Extensive experience with dermatology disease-specific investigator assessments and patient questionnaires.
- Experience with MOHS surgeries, skin biopsies, PK, and biomarkers
- Extensive experience with central medical and clinical photography and vendors.
- Bi-annual all-staff CITI GCP training.
- Annual all-staff OSHA, HIPAA, and CMS Fraud Waste and Abuse trainings.
- IATA-certified research staff.
- All staff BLS certification.
Your safety and quality of life come first
No cost to you
Our research sites offer new and existing treatments at no cost to participating patients.
Safety comes first
Our care team monitors your health throughout the trial with routine safety tests and regular check-ins with our licensed investigators.
Always voluntary
A clinical trial isn’t the right fit for everyone. If it isn’t right for you, our team will help you find the best personalized care option.
Current Trials
Chronic Spontaneous Urticaria
Chronic spontaneous urticaria is mast cell-driven disease marked by the presence of itchy wheals (hives), angioedema, or both for over six weeks. While CU can be spontaneous (no identifiable trigger) or inducible (caused by a known trigger such as pressure or sun exposure), this trial will focus specifically on the spontaneous type. Help us learn more about the benefits of available treatments and the effects this condition has on quality of life by participating in this observational trial.
Qualified Participants Must:
- Be at least 18 years of age
- Have a diagnosis of primary CSU
- Have inadequate control of CSU despite receiving one or more antihistamines
- Be willing to complete daily entries about their condition via electronic means
Qualified Participants May:
- See a study doctor at no cost
- Receive compensation for time and travel
Additional criteria may apply.
Moderate to Severe Plaque Psoriasis
Plaque psoriasis is caused by an overactive immune system, resulting in raised skin patches that can be discolored, dry and itchy. While there’s currently no cure for plaque psoriasis, treatment may be able to alleviate symptoms. Learn more about a clinical trial evaluating the effectiveness of an investigational medication for adults with plaque psoriasis.
Qualified Participants Must:
- Be between 18 and 79 years of age
- Have a diagnosis of moderate to severe plaque psoriasis for at least 6 months
- Have plaque psoriasis covering at least 10% of your body
Qualified Participants May:
- See a study doctor at no cost
- Receive access to an injectable medication being studied for plaque psoriasis
- Receive compensation for time and travel
Additional criteria may apply.
Chronic Hand Eczema
This is a long-lasting inflammatory skin condition affecting the palms and/or dorsal surfaces of the hands that can cause redness, itching, scaling, cracking, pain, and sometimes blistering. Because the hands are used constantly throughout the day, chronic hand eczema can significantly interfere with work, daily activities, and quality of life. This observational registry is designed to help researchers better understand chronic hand eczema, current treatment patterns, and how the condition affects patients over time. By participating, you can help advance research that may improve future care for people living with chronic hand eczema.
Qualified Participants Must:
- Be at least 18 years of age
- Have a diagnosis of chronic hand eczema
- Be willing to participate in periodic study visits
- Be willing to complete questionnaires electronically on a personal device
Additional criteria may apply
Vitiligo
Vitiligo is an autoimmune skin condition that causes patches of skin to lose their natural pigment, resulting in white or lighter-colored areas that may gradually enlarge over time. Although vitiligo is not contagious or physically harmful, it can have a significant emotional and social impact on those living with the condition. This observational registry is designed to help researchers better understand vitiligo, current treatment approaches, and how the disease affects quality of life. By participating, you can help advance research that may improve care for individuals with vitiligo.
Qualified Participants Must:
- Have a diagnosis of vitiligo.
- Be at least 12 years of age or older and provide parental consent, if applicable
- You are either starting a new vitiligo treatment or are already being followed for your vitiligo care.
- Be willing to participate in periodic study visits and questionnaires needed for the registry.
Additional criteria may apply
Palmoplantar Psoriasis Clinical Research Study
Palmoplantar psoriasis is a form of psoriasis that affects the palms of the hands and the soles of the feet. It can cause thickened, scaly, inflamed patches of skin that may be painful, itchy, and interfere with everyday activities. Learn more about a clinical research study evaluating the safety and effectiveness of an investigational oral medication, Zasocitinib (TAK-279), for adults with moderate to severe palmoplantar psoriasis.
Qualified Participants Must:
- Be 18 years of age or older.
- Have a diagnosis of non-pustular palmoplantar psoriasis for at least 6 months.
- Have moderate to severe psoriasis affecting the palms of the hands and/or soles of the feet.
- Also have at least one plaque affecting another area of the body.
- Have psoriasis that has not been adequately controlled with previous topical treatments, phototherapy, and/or systemic treatments.
- Meet additional study eligibility requirements.
Qualified Participants May:
- Receive study-related medical evaluations and monitoring.
- Receive an investigational oral medication being studied for palmoplantar psoriasis.
- Have the opportunity to contribute to research that may help advance future treatment options for palmoplantar psoriasis.
Additional eligibility criteria apply. Participation is voluntary, and a study team member can provide more information about the study and determine whether you may qualify.
To learn more about a trial, contact our research team at researchadmin@clearchoicederm.com or 1-888-729-4999 Ext 149.
Our research sites
Interested in a current study? Call1-888-729-4999